This page shows Safety Shot (SHOT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 looked less like an operating breakthrough and more like a balance-sheet recapitalization keeping a still-cash-burning business moving.
The unusual combination of positive gross margin at58.5% and operating cash burn of-$25.3M in the latest year says the core product stopped losing money on each sale, but the company still consumed cash mainly through overhead. Gross profit of$1.2M was far too small to cover SG&A of$35.7M , so better product economics did not translate into a self-funding operating model.
The balance sheet improved because capital came in from outside, not because the business generated it: equity turned positive to
The larger asset base is not a pile of liquid resources: cash was only
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Safety Shot's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Safety Shot's revenue surged 201.6% year-over-year to $2.1M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Safety Shot carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
Safety Shot's current ratio of 1.01 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Safety Shot generates a -194.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
Safety Shot passes 3 of 9 financial strength tests. 1 of 3 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Safety Shot generates $0.37 in operating cash flow (-$25.3M OCF vs -$68.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Safety Shot generated $2.1M in revenue in fiscal year 2025. This represents an increase of 201.6% from the prior year.
Safety Shot reported -$68.2M in net income in fiscal year 2025.
Safety Shot earned $-17.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 46.4% from the prior year.
Cash & Balance Sheet
Safety Shot held $2.3M in cash against $0 in long-term debt as of fiscal year 2025.
Safety Shot had 184M shares outstanding in fiscal year 2025. This represents an increase of 10179.6% from the prior year.
Margins & Returns
Safety Shot's gross margin was -27.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 321.3 percentage points from the prior year.
Safety Shot's net profit margin was -3220.4% in fiscal year 2025, showing the share of revenue converted to profit.
Safety Shot's ROE was -194.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Safety Shot invested $24K in research and development in fiscal year 2025. This represents a decrease of 76.0% from the prior year.
SHOT Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $786K+52.6% | $515K-66.0% | $1.5M+3270.2% | $45K+6.8% | $42K | N/A | $110K-84.5% | $710K |
| Cost of Revenue | $744K-36.3% | $1.2M-21.1% | $1.5M+6927.8% | $21K-0.2% | $21K | N/A | $402K-20.2% | $505K |
| Gross Profit | $42K+106.5% | -$653K-220.3% | $543K+2174.7% | $24K+13.8% | $21K | N/A | -$292K-242.0% | $206K |
| R&D Expenses | $300 | $0-100.0% | $9K+33.0% | $7K-27.6% | $9K | N/A | $10K-91.4% | $120K |
| SG&A Expenses | $2.2M-74.6% | $8.7M-49.3% | $17.2M+294.5% | $4.4M-19.4% | $5.4M | N/A | $11.3M+31.7% | $8.6M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | $133K+14.9% | $115K+25.6% | $92K | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$1.8M+95.7% | -$42.7M-27.0% | -$33.6M-351.1% | $13.4M+351.1% | -$5.3M | N/A | -$11.9M-44.2% | -$8.3M |
| EPS (Diluted) | N/A | N/A | N/A | $0.09+212.5% | $-0.08 | N/A | $-0.21-31.2% | $-0.16 |
SHOT Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $38.4M-6.3% | $41.0M-49.4% | $81.0M+92.6% | $42.1M+383.8% | $8.7M+18.5% | $7.3M-12.4% | $8.4M-21.7% | $10.7M |
| Current Assets | $6.5M+8.4% | $6.0M-89.7% | $58.5M+166.6% | $21.9M+444.3% | $4.0M+56.2% | $2.6M-25.8% | $3.5M-41.6% | $5.9M |
| Cash & Equivalents | $729K-68.0% | $2.3M-74.6% | $9.0M+1819.5% | $467K+41.8% | $329K-5.6% | $349K-74.4% | $1.4M-57.8% | $3.2M |
| Inventory | $757K-20.3% | $949K+6.6% | $891K+5.9% | $841K+148.0% | $339K+45.2% | $234K-55.4% | $524K-29.2% | $739K |
| Accounts Receivable | $730K+709.8% | $90K-74.8% | $358K+197.8% | $120K+318.8% | $29K-89.9% | $284K+5320.8% | $5K-96.8% | $162K |
| Goodwill | $14.1M0.0% | $14.1M+12.3% | $12.6M0.0% | $12.6M | N/A | $0 | N/A | N/A |
| Total Liabilities | $5.1M-14.6% | $6.0M+8.2% | $5.5M-70.9% | $19.0M+105.5% | $9.2M-2.9% | $9.5M+376.3% | $2.0M-52.7% | $4.2M |
| Current Liabilities | $5.1M-14.6% | $6.0M+8.2% | $5.5M-70.8% | $18.9M+106.1% | $9.2M-2.3% | $9.4M+414.2% | $1.8M-45.8% | $3.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $33.3M-4.9% | $35.0M-53.7% | $75.5M+227.1% | $23.1M+4354.8% | -$543K+75.0% | -$2.2M-134.1% | $6.4M-1.4% | $6.5M |
| Retained Earnings | -$185.3M-1.0% | -$183.5M-30.3% | -$140.8M-31.3% | -$107.3M+10.9% | -$120.4M-4.6% | -$115.1M-13.3% | -$101.6M-13.3% | -$89.6M |
SHOT Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M+68.8% | -$6.2M+51.4% | -$12.8M-672.6% | -$1.7M+64.3% | -$4.6M-445.8% | -$848K+83.5% | -$5.1M+10.0% | -$5.7M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $392K+184.1% | -$467K-107.1% | $6.5M+5317.0% | $121K+133.2% | -$363K-43.9% | -$253K+60.1% | -$633K-985.1% | $71K |
| Financing Cash Flow | N/A | $3-100.0% | $14.7M+782.1% | $1.7M-66.4% | $5.0M+531.3% | $788K-81.3% | $4.2M-38.3% | $6.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SHOT Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 5.4%+132.1pp | -126.7%-162.6pp | 35.9%-17.3pp | 53.1%+3.3pp | 49.9% | N/A | -265.1%-294.1pp | 29.0% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -232.5%+8042.4pp | -8274.9%-6058.1pp | -2216.9%-31973.3pp | 29756.5%+42409.2pp | -12652.8% | N/A | -10823.8%-9658.9pp | -1165.0% |
| Return on Equity | -5.5%+116.4pp | -121.9%-77.4pp | -44.5%-102.4pp | 57.9% | N/A | N/A | -187.0%-59.1pp | -127.9% |
| Return on Assets | -4.8%+99.3pp | -104.1%-62.7pp | -41.4%-73.2pp | 31.8%+93.1pp | -61.3% | N/A | -142.4%-65.1pp | -77.4% |
| Current Ratio | 1.28+0.3 | 1.01-9.6 | 10.59+9.4 | 1.16+0.7 | 0.44+0.2 | 0.27-1.6 | 1.90+0.1 | 1.76 |
| Debt-to-Equity | 0.15-0.0 | 0.17+0.1 | 0.07-0.7 | 0.82+17.8 | -17.02-12.6 | -4.38-4.7 | 0.31-0.3 | 0.65 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Safety Shot's annual revenue?
Safety Shot (SHOT) reported $2.1M in total revenue for fiscal year 2025. This represents a 201.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Safety Shot's revenue growing?
Safety Shot (SHOT) revenue grew by 201.6% year-over-year, from $702K to $2.1M in fiscal year 2025.
Is Safety Shot profitable?
No, Safety Shot (SHOT) reported a net income of -$68.2M in fiscal year 2025, with a net profit margin of -3220.4%.
What is Safety Shot's gross margin?
Safety Shot (SHOT) had a gross margin of -27.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Safety Shot's net profit margin?
Safety Shot (SHOT) had a net profit margin of -3220.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Safety Shot's return on equity (ROE)?
Safety Shot (SHOT) has a return on equity of -194.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Safety Shot's operating cash flow?
Safety Shot (SHOT) generated -$25.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Safety Shot's total assets?
Safety Shot (SHOT) had $41.0M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Safety Shot spend on research and development?
Safety Shot (SHOT) invested $24K in research and development during fiscal year 2025.
What is Safety Shot's current ratio?
Safety Shot (SHOT) had a current ratio of 1.01 as of fiscal year 2025, which is considered adequate.
What is Safety Shot's debt-to-equity ratio?
Safety Shot (SHOT) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Safety Shot's return on assets (ROA)?
Safety Shot (SHOT) had a return on assets of -166.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Safety Shot's cash runway?
Based on fiscal year 2025 data, Safety Shot (SHOT) had $2.3M in cash against an annual operating cash burn of $25.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Safety Shot's Piotroski F-Score?
Safety Shot (SHOT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Safety Shot's earnings high quality?
Safety Shot (SHOT) has an earnings quality ratio of 0.37x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Safety Shot?
Safety Shot (SHOT) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.